Koninklijke DSM (OTCMKTS: RDSMY – Get Rating) – Equities researchers at Jefferies Financial Group reduced their FY2022 earnings estimates for Koninklijke DSM in a research report issued on Thursday, May 12th. Jefferies Financial Group analyst C. Counihan now expects that the basic materials company will post earnings per share of $ 1.26 for the year, down from their prior estimate of $ 1.34. Jefferies Financial Group also issued estimates for Koninklijke DSM’s FY2023 earnings at $ 1.41 EPS, FY2024 earnings at $ 1.59 EPS and FY2025 earnings at $ 1.74 EPS.
A number of other research analysts have also commented on RDSMY. Credit Suisse Group lowered their price target on Koninklijke DSM from € 205.00 ($ 215.79) to € 182.00 ($ 191.58) and set an “outperform” rating for the company in a research report on Thursday, February 17th. Zacks Investment Research raised shares of Koninklijke DSM from a “sell” rating to a “hold” rating in a research report on Tuesday, February 15th. UBS Group reduced their price target on shares of Koninklijke DSM from € 190.00 ($ 200.00) to € 185.00 ($ 194.74) and set a “buy” rating on the stock in a research report on Thursday, March 31st. Barclays lowered their price objective on shares of Koninklijke DSM from € 193.00 ($ 203.16) to € 189.00 ($ 198.95) in a report on Tuesday, March 29th. Finally, Morgan Stanley decreased their target price on Koninklijke DSM from € 166.00 ($ 174.74) to € 155.00 ($ 163.16) and set an “equal weight” rating for the company in a research report on Monday, March 28th. Four analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. According to data from MarketBeat, Koninklijke DSM presently has an average rating of “Buy” and an average target price of $ 177.75.
Shares of RDSMY stock opened at $ 36.63 on Friday. The business has a 50-day moving average of $ 42.41 and a 200 day moving average of $ 48.55. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.58 and a current ratio of 2.52. Koninklijke DSM has a 1-year low of $ 36.22 and a 1-year high of $ 56.92.
The firms also recently announced a dividend, which will be paid on Friday, June 10th. Shareholders of record on Monday, May 16th will be issued a dividend of $ 0.3593 per share. The ex-dividend date is Friday, May 13th. This represents a yield of 1.5%.
Koninklijke DSM Company Profile (Get Rating)
Koninklijke DSM NV, a science-based company, engages in nutrition, health, and sustainable living businesses in the Netherlands, Switzerland, rest of Europe, North America, Latin America, China, rest of Asia, and internationally. It operates through Nutrition, Materials, and Innovation Center segments.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to [email protected]
Should you invest $ 1,000 in Koninklijke DSM right now?
Before you consider Koninklijke DSM, you’ll want to hear this.
MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on … and Koninklijke DSM wasn’t on the list.
While Koninklijke DSM currently has a “Buy” rating among analysts, top-rated analysts believe these five stocks are better buys.
View The 5 Stocks Here